ATG101
gene geneOn this page
Also known as FLJ11773
Summary
ATG101 (autophagy related 101, HGNC:25679) is a protein-coding gene on chromosome 12q13.13, encoding Autophagy-related protein 101 (Q9BSB4). Autophagy factor required for autophagosome formation.
Enables identical protein binding activity. Involved in autophagosome assembly and negative regulation of cell population proliferation. Located in phagophore assembly site. Part of Atg1/ULK1 kinase complex. Biomarker of cholangiocarcinoma; colon cancer; and hepatocellular carcinoma.
Source: NCBI Gene 60673 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 40 total
- MANE Select transcript:
NM_021934
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25679 |
| Approved symbol | ATG101 |
| Name | autophagy related 101 |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11773 |
| Ensembl gene | ENSG00000123395 |
| Ensembl biotype | protein_coding |
| OMIM | 615089 |
| Entrez | 60673 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 12 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000336854, ENST00000547409, ENST00000548915, ENST00000550604, ENST00000552544, ENST00000552947, ENST00000553049, ENST00000908677, ENST00000908678, ENST00000938048, ENST00000938049, ENST00000938050, ENST00000938051, ENST00000938052, ENST00000938053
RefSeq mRNA: 2 — MANE Select: NM_021934
NM_001098673, NM_021934
CCDS: CCDS8820
Canonical transcript exons
ENST00000336854 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001060717 | 52070354 | 52070483 |
| ENSE00001331249 | 52073575 | 52073902 |
| ENSE00001348222 | 52076786 | 52077495 |
| ENSE00001423435 | 52069978 | 52070242 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 96.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2122 / max 129.2132, expressed in 1811 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 125570 | 22.0794 | 1811 |
| 125571 | 0.1328 | 12 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 96.25 | gold quality |
| parotid gland | UBERON:0001831 | 93.14 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.71 | gold quality |
| body of stomach | UBERON:0001161 | 92.58 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.70 | gold quality |
| skin of leg | UBERON:0001511 | 91.61 | gold quality |
| gall bladder | UBERON:0002110 | 91.48 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.06 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 90.98 | gold quality |
| left testis | UBERON:0004533 | 90.94 | gold quality |
| granulocyte | CL:0000094 | 90.85 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.77 | gold quality |
| right testis | UBERON:0004534 | 90.69 | gold quality |
| minor salivary gland | UBERON:0001830 | 90.66 | gold quality |
| gastrocnemius | UBERON:0001388 | 90.56 | gold quality |
| zone of skin | UBERON:0000014 | 90.24 | gold quality |
| muscle of leg | UBERON:0001383 | 90.24 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 90.23 | gold quality |
| stomach | UBERON:0000945 | 90.15 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.11 | gold quality |
| monocyte | CL:0000576 | 89.96 | gold quality |
| ascending aorta | UBERON:0001496 | 89.95 | gold quality |
| testis | UBERON:0000473 | 89.93 | gold quality |
| left uterine tube | UBERON:0001303 | 89.91 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.83 | gold quality |
| thoracic aorta | UBERON:0001515 | 89.80 | gold quality |
| apex of heart | UBERON:0002098 | 89.78 | gold quality |
| mononuclear cell | CL:0000842 | 89.73 | gold quality |
| mouth mucosa | UBERON:0003729 | 89.73 | gold quality |
| upper lobe of lung | UBERON:0008948 | 89.69 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-93593 | yes | 7.66 |
| E-ANND-3 | yes | 6.81 |
| E-CURD-11 | no | 99.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting ATG101, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-3136-3P | 99.57 | 66.59 | 781 |
| HSA-MIR-7155-3P | 99.57 | 66.48 | 794 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6827-5P | 98.46 | 64.88 | 1256 |
| HSA-MIR-6511A-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-6511B-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-12115 | 94.19 | 66.37 | 738 |
Literature-anchored findings (GeneRIF, showing 9)
- The identification of the novel protein, Atg101, and the validation of Atg13 and Atg101 as ULK1-interacting proteins, suggests an Atg1 complex is involved in the induction of macroautophagy in mammalian cells. (PMID:19287211)
- These data suggest that Atg101 is a novel Atg protein that functions together with ULK, Atg13 and FIP200. (PMID:19597335)
- Data indicate mitogen lacritin stimulates FOXO3-ATG101 and FOXO1-ATG7 autophagic coupling and restores metabolic homeostasis. (PMID:23640897)
- Structure of the human Atg13-Atg101 HORMA heterodimer in the ULK1 complex that controls autophagy has been described. (PMID:26299944)
- The C-terminal deletion of ATG101 shows a significant defect in the interaction with PtdIns3K components and subsequently impairs autophagosome formation. This result clearly presents an additional role of ATG101 for bridging the ULK1 and PtdIns3K complexes in the mammalian autophagy process. (PMID:30081750)
- ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells. (PMID:34502089)
- ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma. (PMID:36302799)
- Metamorphosis by ATG13 and ATG101 in human autophagy initiation. (PMID:37394799)
- The role of the HORMA domain proteins ATG13 and ATG101 in initiating autophagosome biogenesis. (PMID:37567770)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | atg101 | ENSDARG00000043287 |
| mus_musculus | Atg101 | ENSMUSG00000037204 |
| rattus_norvegicus | Atg101 | ENSRNOG00000007756 |
| drosophila_melanogaster | Atg101 | FBGN0030960 |
| caenorhabditis_elegans | WBGENE00022078 |
Protein
Protein identifiers
Autophagy-related protein 101 — Q9BSB4 (reviewed: Q9BSB4)
All UniProt accessions (4): Q9BSB4, F8VQD9, F8VVA0, H3BMZ4
UniProt curated annotations — full annotation on UniProt →
Function. Autophagy factor required for autophagosome formation. Stabilizes ATG13, protecting it from proteasomal degradation.
Subunit / interactions. Interacts with ATG13. Associates with a complex composed of ATG13, ULK1 and RB1CC1; the association with this complex requires the presence of ATG13.
Subcellular location. Cytoplasm. Preautophagosomal structure.
Similarity. Belongs to the ATG101 family.
RefSeq proteins (2): NP_001092143, NP_068753* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012445 | ATG101 | Family |
Pfam: PF07855
UniProt features (28 total): strand 13, helix 7, mutagenesis site 5, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
8 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5C50 | X-RAY DIFFRACTION | 1.63 |
| 4WZG | X-RAY DIFFRACTION | 1.9 |
| 5XUY | X-RAY DIFFRACTION | 2.2 |
| 8DO8 | X-RAY DIFFRACTION | 2.41 |
| 5XV6 | X-RAY DIFFRACTION | 2.46 |
| 5XV1 | X-RAY DIFFRACTION | 2.51 |
| 5XV3 | X-RAY DIFFRACTION | 2.57 |
| 5XV4 | X-RAY DIFFRACTION | 2.95 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSB4-F1 | 90.30 | 0.81 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (5):
| Position | Phenotype |
|---|---|
| 31 | impairs interaction with atg13; when associated with r-54. |
| 54 | impairs interaction with atg13; when associated with s-31. |
| 152 | abolishes interaction with atg13; when associated with d-153 and d-156. |
| 153 | abolishes interaction with atg13; when associated with d-152 and d-156. |
| 156 | abolishes interaction with atg13; when associated with d-152 and d-152. |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1632852 | Macroautophagy |
| R-HSA-9612973 | Autophagy |
MSigDB gene sets: 163 (showing top):
GOBP_REGULATION_OF_AUTOPHAGY, GOBP_VACUOLE_ORGANIZATION, GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, NAGASHIMA_NRG1_SIGNALING_UP, GOBP_MACROAUTOPHAGY, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, WCTCNATGGY_UNKNOWN, GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY, GOBP_AUTOPHAGOSOME_ORGANIZATION, GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS
GO Biological Process (4): autophagosome assembly (GO:0000045), negative regulation of cell population proliferation (GO:0008285), positive regulation of autophagy (GO:0010508), autophagy (GO:0006914)
GO Molecular Function (4): protein kinase binding (GO:0019901), identical protein binding (GO:0042802), protein-containing complex binding (GO:0044877), protein binding (GO:0005515)
GO Cellular Component (5): phagophore assembly site (GO:0000407), endoplasmic reticulum membrane (GO:0005789), cytosol (GO:0005829), Atg1/ULK1 kinase complex (GO:1990316), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Autophagy | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 3 |
| cellular anatomical structure | 3 |
| binding | 2 |
| Atg12 activating enzyme activity | 1 |
| protein-phosphatidylethanolamide deconjugating activity | 1 |
| Atg12 conjugating enzyme activity | 1 |
| Atg12 ligase activity | 1 |
| organelle assembly | 1 |
| Atg1/ULK1 kinase complex assembly | 1 |
| autophagosome organization | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| negative regulation of cellular process | 1 |
| autophagy | 1 |
| positive regulation of catabolic process | 1 |
| regulation of autophagy | 1 |
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| kinase binding | 1 |
| protein binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| serine/threonine protein kinase complex | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1186 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ATG101 | RB1CC1 | Q8TDY2 | 998 |
| ATG101 | ULK1 | O75385 | 998 |
| ATG101 | ATG13 | O75143 | 998 |
| ATG101 | ULK2 | Q8IYT8 | 997 |
| ATG101 | CIB1 | Q99828 | 922 |
| ATG101 | ATG5 | Q9H1Y0 | 897 |
| ATG101 | ATG14 | Q6ZNE5 | 892 |
| ATG101 | WIPI1 | Q5MNZ9 | 875 |
| ATG101 | PIK3C3 | Q8NEB9 | 864 |
| ATG101 | PIK3R4 | Q99570 | 863 |
| ATG101 | ATG12 | O94817 | 857 |
| ATG101 | BECN1 | Q14457 | 845 |
| ATG101 | ATG16L1 | Q676U5 | 845 |
| ATG101 | ATG10 | Q9H0Y0 | 840 |
| ATG101 | ATG3 | Q9NT62 | 839 |
IntAct
68 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATG101 | ATG13 | psi-mi:“MI:0914”(association) | 0.950 |
| ATG13 | ATG101 | psi-mi:“MI:0915”(physical association) | 0.950 |
| ATG101 | ATG13 | psi-mi:“MI:0915”(physical association) | 0.950 |
| ATG13 | ATG101 | psi-mi:“MI:0407”(direct interaction) | 0.950 |
| ATG13 | ULK1 | psi-mi:“MI:0914”(association) | 0.940 |
| ULK1 | ATG13 | psi-mi:“MI:0914”(association) | 0.940 |
| ATG13 | ULK1 | psi-mi:“MI:2364”(proximity) | 0.940 |
| RB1CC1 | ATG101 | psi-mi:“MI:0915”(physical association) | 0.860 |
| HUS1 | RAD1 | psi-mi:“MI:0914”(association) | 0.840 |
| RB1CC1 | ATG13 | psi-mi:“MI:0914”(association) | 0.820 |
| MAP1LC3C | ATG13 | psi-mi:“MI:0914”(association) | 0.750 |
| BRK1 | HSBP1 | psi-mi:“MI:0914”(association) | 0.740 |
| MAP1LC3B | ATG13 | psi-mi:“MI:0914”(association) | 0.730 |
| ATG101 | MAP1LC3C | psi-mi:“MI:0407”(direct interaction) | 0.730 |
| ATG101 | MAP1LC3C | psi-mi:“MI:0915”(physical association) | 0.730 |
BioGRID (236): ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), RB1CC1 (Affinity Capture-Western), ATG13 (Affinity Capture-Western), ULK1 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-Western), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), ATG101 (Affinity Capture-MS)
ESM2 similar proteins: A4IH75, B0S6R1, F4K265, O14417, O75165, O94915, P28660, P60670, P97878, Q10LJ0, Q2HJE0, Q2TBN7, Q3B736, Q3B8G8, Q3TPX4, Q499N2, Q4R6Q7, Q4R708, Q556Y9, Q5E9X5, Q5R6U8, Q5R8B7, Q5RBT3, Q5VZE5, Q5XHA1, Q5ZHV2, Q642Q3, Q6AY69, Q6DE58, Q6DKG0, Q6GLR7, Q6NPF4, Q6P2C8, Q6PFL0, Q6PHQ8, Q6Q7J5, Q7T322, Q8BJ63, Q8TAT6, Q8VDP2
Diamond homologs: A4IH75, Q2HJE0, Q3B736, Q6AY69, Q6DE58, Q9BSB4, Q9D8Z6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| ATG101 | up-regulates | ATG13 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 41 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Macroautophagy | 11 | 47.0× | 3e-14 |
| Autophagy | 5 | 27.5× | 5e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitophagy | 9 | 79.5× | 2e-13 |
| autophagosome assembly | 11 | 68.7× | 1e-15 |
| autophagosome maturation | 6 | 58.5× | 5e-08 |
| positive regulation of autophagy | 5 | 28.9× | 3e-05 |
| autophagy | 6 | 18.4× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
894 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:52076781:CCCA:C | acceptor_loss | 1.0000 |
| 12:52076783:CAGGA:C | acceptor_loss | 1.0000 |
| 12:52076784:A:AC | acceptor_loss | 1.0000 |
| 12:52076784:A:AG | acceptor_gain | 1.0000 |
| 12:52076784:AG:A | acceptor_gain | 1.0000 |
| 12:52076784:AGGAT:A | acceptor_gain | 1.0000 |
| 12:52076785:G:GT | acceptor_gain | 1.0000 |
| 12:52076785:GG:G | acceptor_gain | 1.0000 |
| 12:52076785:GGA:G | acceptor_gain | 1.0000 |
| 12:52076785:GGAT:G | acceptor_gain | 1.0000 |
| 12:52076785:GGATG:G | acceptor_gain | 1.0000 |
| 12:52070025:A:T | donor_gain | 0.9800 |
| 12:52070432:G:GT | donor_gain | 0.9800 |
| 12:52073886:T:TA | donor_gain | 0.9800 |
| 12:52073887:T:TA | donor_gain | 0.9800 |
| 12:52073900:AAGG:A | donor_loss | 0.9800 |
| 12:52073901:AG:A | donor_loss | 0.9800 |
| 12:52073902:GGTAA:G | donor_loss | 0.9800 |
| 12:52073903:GTAAG:G | donor_loss | 0.9800 |
| 12:52073904:T:TC | donor_loss | 0.9800 |
| 12:52070033:G:GA | donor_gain | 0.9700 |
| 12:52070046:C:T | donor_gain | 0.9700 |
| 12:52070061:G:GA | donor_gain | 0.9700 |
| 12:52070069:G:T | donor_gain | 0.9700 |
| 12:52070436:GGCA:G | donor_gain | 0.9700 |
| 12:52072497:C:G | donor_gain | 0.9700 |
| 12:52073902:GGT:G | donor_gain | 0.9700 |
| 12:52070240:G:GT | donor_gain | 0.9600 |
| 12:52070455:G:GT | donor_gain | 0.9600 |
| 12:52070479:TCAAG:T | donor_loss | 0.9600 |
AlphaMissense
1421 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:52073744:C:A | R32S | 1.000 |
| 12:52076838:T:C | F102S | 1.000 |
| 12:52076861:T:A | W110R | 1.000 |
| 12:52076861:T:C | W110R | 1.000 |
| 12:52076888:T:A | W119R | 1.000 |
| 12:52076888:T:C | W119R | 1.000 |
| 12:52076890:G:C | W119C | 1.000 |
| 12:52076890:G:T | W119C | 1.000 |
| 12:52076897:T:A | W122R | 1.000 |
| 12:52076897:T:C | W122R | 1.000 |
| 12:52077066:T:C | F178S | 1.000 |
| 12:52077168:T:A | I212N | 1.000 |
| 12:52073745:G:C | R32P | 0.999 |
| 12:52073747:A:C | S33R | 0.999 |
| 12:52073749:C:A | S33R | 0.999 |
| 12:52073749:C:G | S33R | 0.999 |
| 12:52073753:G:C | G35R | 0.999 |
| 12:52073754:G:A | G35D | 0.999 |
| 12:52073759:T:C | F37L | 0.999 |
| 12:52073760:T:C | F37S | 0.999 |
| 12:52073761:C:A | F37L | 0.999 |
| 12:52073761:C:G | F37L | 0.999 |
| 12:52073783:T:G | Y45D | 0.999 |
| 12:52076837:T:C | F102L | 0.999 |
| 12:52076839:C:A | F102L | 0.999 |
| 12:52076839:C:G | F102L | 0.999 |
| 12:52076863:G:C | W110C | 0.999 |
| 12:52076863:G:T | W110C | 0.999 |
| 12:52076889:G:C | W119S | 0.999 |
| 12:52076943:G:C | R137P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1001053778 (12:52071738 C>T), RS1001149777 (12:52072006 C>T), RS1001155595 (12:52070202 C>T), RS1001268854 (12:52076061 T>C), RS1001379833 (12:52066747 A>G), RS1001379922 (12:52063332 C>A,T), RS1001704666 (12:52068948 G>A), RS1001762535 (12:52075841 A>C,G), RS1001828856 (12:52074716 T>C,G), RS1001837236 (12:52067821 C>T), RS1002091441 (12:52074374 G>T), RS1002707833 (12:52070042 G>C), RS1002788265 (12:52069470 G>A,C), RS1002808292 (12:52063889 GAAAA>G,GAAA,GAAAAA), RS1003035710 (12:52074435 C>T)
Disease associations
OMIM: gene MIM:615089 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004602_156 | Mean corpuscular volume | 4.000000e-11 |
| GCST004630_182 | Mean corpuscular hemoglobin | 4.000000e-12 |
| GCST009391_271 | Metabolite levels | 6.000000e-06 |
| GCST90002392_382 | Mean corpuscular volume | 4.000000e-22 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0010428 | triacylglycerol 56:10 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, decreases reaction | 3 |
| Valproic Acid | affects expression, increases expression | 3 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| fisetin | decreases expression, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| amyloid beta-protein (1-42) | decreases expression, decreases reaction | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| trovafloxacin | increases expression | 1 |
| abrine | increases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Chlorogenic Acid | decreases expression, decreases reaction | 1 |
| Copper | affects binding, decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Dieldrin | increases response to substance | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1KC | Abcam HeLa ATG101 KO | Cancer cell line | Female |
| CVCL_SG01 | HAP1 ATG101 (-) 1 | Cancer cell line | Male |
| CVCL_SG02 | HAP1 ATG101 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.